Cellosaurus 52M51 (CVCL_C3X1)
| Cell line name | 52M51 |
|---|---|
| Accession | CVCL_C3X1 |
| Resource Identification Initiative | To cite this cell line use: 52M51 (RRID:CVCL_C3X1) |
| Comments | Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9405. Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized brontictuzumab (OMP-52M51; 52M51H4L3) therapeutic antibody which was used in clinical trials for the treatment of lymphoid malignancies. Monoclonal antibody isotype: Not specified. Monoclonal antibody target: UniProtKB; P46531; Human NOTCH1. |
| Species of origin | Mus musculus (Mouse) (NCBI Taxonomy: 10090) |
| Category | Hybridoma |
| Publications | Patent=US8435513 |
| Cross-references | |
| Biological sample resources | ABCD; ABCD_AF832 |
| Encyclopedic resources | Wikidata; Q116048264 |
| Entry history | |
| Entry creation | 15-Dec-2022 |
| Last entry update | 21-Mar-2023 |
| Version number | 2 |